These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21850661)

  • 1. Changing patterns of splenectomy in transfusion-dependent thalassemia patients.
    Piga A; Serra M; Longo F; Forni G; Quarta G; Cappellini MD; Galanello R
    Am J Hematol; 2011 Sep; 86(9):808-10. PubMed ID: 21850661
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable response to splenectomy in familial myelodysplastic syndrome.
    Abdul-Wahab J; Naznin M; Suhaimi A; Amir-Hamzah AR
    Singapore Med J; 2007 Jul; 48(7):e206-8. PubMed ID: 17609817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
    Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
    Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation by scintigraphy and blood requirements of secondary hypersplenism after splenectomy in homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G; Cioffi L; Squame G; Celentano L
    Pediatria (Napoli); 1983; 91(1):13-8. PubMed ID: 6889086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of Cooley's anemia.
    Nathan DG
    Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is splenectomy for massive splenomegaly safe in children?
    Al-Salem AH
    Am J Surg; 1999 Jul; 178(1):42-5. PubMed ID: 10456701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy for children with thalassemia.
    Al-Salem AH; Nasserulla Z
    Int Surg; 2002; 87(4):269-73. PubMed ID: 12575813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thalassemia intermedia: apropos of 14 cases].
    Hafsia R; Meddeb B; Sediri K; Hafsia A; Boussen M
    Tunis Med; 1989 Mar; 67(3):173-6. PubMed ID: 2756580
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effect of splenectomy on transfusion requirements in thalassemia major.
    Cohen A; Gayer R; Mizanin J
    Am J Hematol; 1989 Apr; 30(4):254-6. PubMed ID: 2929586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thalassemia intermedia: 36 cases].
    Hafsia R; Ben Salah N; Hafhouf E; Belakhal F; Gouider E; El Borji W; Meddeb B
    Tunis Med; 2010 Feb; 88(2):102-4. PubMed ID: 20415168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythrokinetics and splenic function in thalassemic syndromes].
    Torlontano G; Tata A; Proietti M
    Recenti Prog Med; 1971 Mar; 50(3):246-71. PubMed ID: 5109833
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems related to treatment of beta-thalassaemia major.
    Economidou J
    Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of the improved prognosis in thalassemia major.
    Modell B
    Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.